Cognyte (CGNT) CRO discloses 611,676-share equity stake in Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Cognyte Software Ltd.’s Chief Revenue Officer, Nuri Efraim, has filed an initial Form 3 reporting beneficial ownership of 611,676 Ordinary Shares. This position includes a mix of currently held shares and equity awards such as restricted share units (RSUs) and performance share units (PSUs).
The filing notes RSU and PSU grants made between July 2023 and March 2026, with vesting schedules extending into 2028. These awards convert into Ordinary Shares over time as vesting and performance conditions are met, tying a substantial portion of the CRO’s compensation directly to Cognyte’s future performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Nuri Efraim
Role
Chief Revenue Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 611,676 shares (Direct)
Footnotes (1)
- Includes 12,500 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on July 26, 2023, all of which vest on May 10, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 59,525 Ordinary Shares that are represented by RSUs that were granted on March 24, 2025, of which 11,905 vest on March 24, 2026, 11,905 vest on September 24, 2026, 11,905 vest on March 24, 2027, 11,905 vest on September 24, 2027 and 11,905 vest on March 24, 2028. Includes 136,835 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on March 26, 2024, for which the performance conditions have been met, and which will vest on April 11, 2026. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 36,713 Ordinary Shares that are represented by RSUs that were granted on March 26, 2024, of which 12,237 vest on March 26, 2026, 12,238 vest on September 26, 2026 and 12,238 vest on March 26, 2027. Includes 58,261 Ordinary Shares that are represented by RSUs that were granted on March 16, 2026, and which vest in six equal semi-annual installments beginning six months after the grant date over three years.
FAQ
What does Cognyte (CGNT) Chief Revenue Officer Nuri Efraim report on this Form 3?
Nuri Efraim reports beneficial ownership of 611,676 Cognyte Ordinary Shares on this Form 3. The holding combines existing shares with multiple RSU and PSU awards that convert into shares as vesting and performance conditions are satisfied over coming years.
Are there any buy or sell transactions in Nuri Efraim’s Cognyte (CGNT) Form 3 filing?
No buy or sell transactions are reported; this Form 3 is an initial ownership statement. It lists total Ordinary Shares and equity awards held, without recording new market purchases or sales, giving investors a baseline of the CRO’s existing equity stake.
What equity award types does Cognyte (CGNT) disclose for Nuri Efraim in this filing?
The filing discloses restricted share units (RSUs) and performance share units (PSUs). These instruments each represent a right to receive one Ordinary Share upon settlement, subject to vesting schedules and, for PSUs, satisfaction of specified performance conditions.
Over what period do Nuri Efraim’s Cognyte (CGNT) RSUs and PSUs vest?
The awards were granted between July 2023 and March 2026, with vesting dates running through March 2028. Some RSUs vest in scheduled tranches, while PSUs vest after performance conditions are met and a defined future vesting date is reached.